It has been a pleasure to work with Dr. Malene Jensen. The work that she has done in the Clinical Neuroscience Teams has been impressive. Team members have consistently expressed their satisfaction with her contributions. Through her expertise, leadership and personal commitment the Clinical Project Team has successfully met objectives. Dr Jensen has had a position as Group Manager and by that also been an excellent representative at external interactions for Neuroscience R&D. Following the closure of all AstraZeneca R&D activities in Sodertalje, Dr Jensen’s present position at AstraZeneca will be terminated on October 31th, 2012 and as such this termination does not in any way reflect negatively on her track record. It is my pleasure to give Malene my highest recommendation and I also wish her best of luck in the future. Södertälje May 15, 2012 Siv Karlsson, TA Clinical Director, AstraZeneca

It has been a pleasure to work with Dr. Malene Jensen. The work that she has done in the Clinical Neuroscience Teams has been impressive. Team members have consistently expressed their satisfaction with her contributions. Through her expertise, leadership and personal commitment the Clinical Project Team has successfully met objectives. Dr Jensen has had a position as Group Manager and by that also been an excellent representative at external interactions for Neuroscience R&D. Following the closure of all AstraZeneca R&D activities in Sodertalje, Dr Jensen’s present position at AstraZeneca will be terminated on October 31th, 2012 and as such this termination does not in any way reflect negatively on her track record. It is my pleasure to give Malene my highest recommendation and I also wish her best of luck in the future. Södertälje May 15, 2012 Siv Karlsson, TA Clinical Director, AstraZeneca

It has been a pleasure to work with Dr. Malene Jensen. The work that she has done in the Clinical Neuroscience Teams has been impressive. Team members have consistently expressed their satisfaction with her contributions. Through her expertise, leadership and personal commitment the Clinical Project Team has successfully met objectives. Dr Jensen has had a position as Group Manager and by that also been an excellent representative at external interactions for Neuroscience R&D. Following the closure of all AstraZeneca R&D activities in Sodertalje, Dr Jensen’s present position at AstraZeneca will be terminated on October 31th, 2012 and as such this termination does not in any way reflect negatively on her track record. It is my pleasure to give Malene my highest recommendation and I also wish her best of luck in the future. Södertälje May 15, 2012 Siv Karlsson, TA Clinical Director, AstraZeneca